The traditional prognostic factors, including stage of disease and tum
our grade, have shown a limited prognostic significance and an inabili
ty to predict clinical response to specific treatment in patients with
laryngeal squamous-cell carcinoma. More recent data suggest that cell
kinetics indices, DNA-ploidy, lysosomal cysteine proteinase expressio
n adn genetic changes of both tumour suppressor genes and protooncogen
es may be considered as reliable and reproducible indicators of biolog
ical aggressiveness in these patients. Moreover, the frequency of diff
erent genetic alterations suggests that several pathways are involved
in the genesis of these neoplasias and, in particularly, it is very pr
obable that p-53 expression and PCNA indices (increased in normal muco
sa and preinvasive lesions) may constitute more important biomarkers f
or the early steps of laryngeal carcinogenesis.